During the past decade, Morton Plant Mease Health Care conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Morton Plant Mease Health Care" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 2 trials, followed by "AstraZeneca" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored and "Veru Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Morton Plant Mease Health Care" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "AdventHealth" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Morton Plant Mease Health Care" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Morton Plant Mease Health Care" are "Breast Cancer" (3 trials), "Heart Failure" (3 trials), "Metastatic Breast Cancer" (2 trials), "Aortic Stenosis" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Morton Plant Mease Health Care" in a lesser frequency.

Most popular intervention types in "Morton Plant Mease Health Care" are "Drug" (12 trials), "Device" (4 trials), "Procedure" (3 trials), "Radiation" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AC2993" (2 trials), "Empagliflozin" (2 trials), "0.9% saline" (1 trials) and "3 months of dual antiplatelet therapy (DAPT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Morton Plant Mease Health Care" are 14 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Morton Plant Mease Health Care". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Morton Plant Mease Health Care, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Morton Plant Mease Health Care, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".